[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Beta-Lactam Drugs Market - Global Outlook and Forecast 2021-2027

April 2021 | 91 pages | ID: BB2F7ABCA217EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Beta-Lactam Drugs in Global, including the following market information:

Global Beta-Lactam Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Beta-Lactam Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Beta-Lactam Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Beta-Lactam Drugs Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Beta-Lactam Drugs Market Segment Percentages, By Type, 2020 (%)
  • Penicillin
  • Cephalosporins
  • Carbapenem
  • Monobacteria
China Beta-Lactam Drugs Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Beta-Lactam Drugs Market Segment Percentages, By Application, 2020 (%)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Global Beta-Lactam Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Beta-Lactam Drugs Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Beta-Lactam Drugs Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Beta-Lactam Drugs Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • GlaxoSmithKline plc
  • Pfizer, Inc.
  • AstraZeneca plc
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • Shionogi & Co., Ltd.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Beta-Lactam Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Beta-Lactam Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BETA-LACTAM DRUGS OVERALL MARKET SIZE

2.1 Global Beta-Lactam Drugs Market Size: 2021 VS 2027
2.2 Global Beta-Lactam Drugs Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Beta-Lactam Drugs Players in Global Market
3.2 Top Global Beta-Lactam Drugs Companies Ranked by Revenue
3.3 Global Beta-Lactam Drugs Revenue by Companies
3.4 Top 3 and Top 5 Beta-Lactam Drugs Companies in Global Market, by Revenue in 2020
3.5 Global Companies Beta-Lactam Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Beta-Lactam Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Beta-Lactam Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Beta-Lactam Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Beta-Lactam Drugs Market Size Markets, 2021 & 2027
  4.1.2 Penicillin
  4.1.3 Cephalosporins
  4.1.4 Carbapenem
  4.1.5 Monobacteria
4.2 By Type - Global Beta-Lactam Drugs Revenue & Forecasts
  4.2.1 By Type - Global Beta-Lactam Drugs Revenue, 2016-2021
  4.2.2 By Type - Global Beta-Lactam Drugs Revenue, 2022-2027
  4.2.3 By Type - Global Beta-Lactam Drugs Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Beta-Lactam Drugs Market Size, 2021 & 2027
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Beta-Lactam Drugs Revenue & Forecasts
  5.2.1 By Application - Global Beta-Lactam Drugs Revenue, 2016-2021
  5.2.2 By Application - Global Beta-Lactam Drugs Revenue, 2022-2027
  5.2.3 By Application - Global Beta-Lactam Drugs Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Beta-Lactam Drugs Market Size, 2021 & 2027
6.2 By Region - Global Beta-Lactam Drugs Revenue & Forecasts
  6.2.1 By Region - Global Beta-Lactam Drugs Revenue, 2016-2021
  6.2.2 By Region - Global Beta-Lactam Drugs Revenue, 2022-2027
  6.2.3 By Region - Global Beta-Lactam Drugs Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Beta-Lactam Drugs Revenue, 2016-2027
  6.3.2 US Beta-Lactam Drugs Market Size, 2016-2027
  6.3.3 Canada Beta-Lactam Drugs Market Size, 2016-2027
  6.3.4 Mexico Beta-Lactam Drugs Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Beta-Lactam Drugs Revenue, 2016-2027
  6.4.2 Germany Beta-Lactam Drugs Market Size, 2016-2027
  6.4.3 France Beta-Lactam Drugs Market Size, 2016-2027
  6.4.4 U.K. Beta-Lactam Drugs Market Size, 2016-2027
  6.4.5 Italy Beta-Lactam Drugs Market Size, 2016-2027
  6.4.6 Russia Beta-Lactam Drugs Market Size, 2016-2027
  6.4.7 Nordic Countries Beta-Lactam Drugs Market Size, 2016-2027
  6.4.8 Benelux Beta-Lactam Drugs Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Beta-Lactam Drugs Revenue, 2016-2027
  6.5.2 China Beta-Lactam Drugs Market Size, 2016-2027
  6.5.3 Japan Beta-Lactam Drugs Market Size, 2016-2027
  6.5.4 South Korea Beta-Lactam Drugs Market Size, 2016-2027
  6.5.5 Southeast Asia Beta-Lactam Drugs Market Size, 2016-2027
  6.5.6 India Beta-Lactam Drugs Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Beta-Lactam Drugs Revenue, 2016-2027
  6.6.2 Brazil Beta-Lactam Drugs Market Size, 2016-2027
  6.6.3 Argentina Beta-Lactam Drugs Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Beta-Lactam Drugs Revenue, 2016-2027
  6.7.2 Turkey Beta-Lactam Drugs Market Size, 2016-2027
  6.7.3 Israel Beta-Lactam Drugs Market Size, 2016-2027
  6.7.4 Saudi Arabia Beta-Lactam Drugs Market Size, 2016-2027
  6.7.5 UAE Beta-Lactam Drugs Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 GlaxoSmithKline plc
  7.1.1 GlaxoSmithKline plc Corporate Summary
  7.1.2 GlaxoSmithKline plc Business Overview
  7.1.3 GlaxoSmithKline plc Beta-Lactam Drugs Major Product Offerings
  7.1.4 GlaxoSmithKline plc Beta-Lactam Drugs Revenue in Global (2016-2021)
  7.1.5 GlaxoSmithKline plc Key News
7.2 Pfizer, Inc.
  7.2.1 Pfizer, Inc. Corporate Summary
  7.2.2 Pfizer, Inc. Business Overview
  7.2.3 Pfizer, Inc. Beta-Lactam Drugs Major Product Offerings
  7.2.4 Pfizer, Inc. Beta-Lactam Drugs Revenue in Global (2016-2021)
  7.2.5 Pfizer, Inc. Key News
7.3 AstraZeneca plc
  7.3.1 AstraZeneca plc Corporate Summary
  7.3.2 AstraZeneca plc Business Overview
  7.3.3 AstraZeneca plc Beta-Lactam Drugs Major Product Offerings
  7.3.4 AstraZeneca plc Beta-Lactam Drugs Revenue in Global (2016-2021)
  7.3.5 AstraZeneca plc Key News
7.4 Merck & Co., Inc.
  7.4.1 Merck & Co., Inc. Corporate Summary
  7.4.2 Merck & Co., Inc. Business Overview
  7.4.3 Merck & Co., Inc. Beta-Lactam Drugs Major Product Offerings
  7.4.4 Merck & Co., Inc. Beta-Lactam Drugs Revenue in Global (2016-2021)
  7.4.5 Merck & Co., Inc. Key News
7.5 Eli Lilly and Company
  7.5.1 Eli Lilly and Company Corporate Summary
  7.5.2 Eli Lilly and Company Business Overview
  7.5.3 Eli Lilly and Company Beta-Lactam Drugs Major Product Offerings
  7.5.4 Eli Lilly and Company Beta-Lactam Drugs Revenue in Global (2016-2021)
  7.5.5 Eli Lilly and Company Key News
7.6 Shionogi & Co., Ltd.
  7.6.1 Shionogi & Co., Ltd. Corporate Summary
  7.6.2 Shionogi & Co., Ltd. Business Overview
  7.6.3 Shionogi & Co., Ltd. Beta-Lactam Drugs Major Product Offerings
  7.6.4 Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue in Global (2016-2021)
  7.6.5 Shionogi & Co., Ltd. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Beta-Lactam Drugs Market Opportunities & Trends in Global Market
Table 2. Beta-Lactam Drugs Market Drivers in Global Market
Table 3. Beta-Lactam Drugs Market Restraints in Global Market
Table 4. Key Players of Beta-Lactam Drugs in Global Market
Table 5. Top Beta-Lactam Drugs Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Beta-Lactam Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Beta-Lactam Drugs Revenue Share by Companies, 2016-2021
Table 8. Global Companies Beta-Lactam Drugs Product Type
Table 9. List of Global Tier 1 Beta-Lactam Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Beta-Lactam Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Beta-Lactam Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Beta-Lactam Drugs Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Beta-Lactam Drugs Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Beta-Lactam Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Beta-Lactam Drugs Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Beta-Lactam Drugs Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Beta-Lactam Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Beta-Lactam Drugs Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Beta-Lactam Drugs Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Beta-Lactam Drugs Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Beta-Lactam Drugs Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Beta-Lactam Drugs Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Beta-Lactam Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Beta-Lactam Drugs Revenue, (US$, Mn), 2022-2027
Table 30. GlaxoSmithKline plc Corporate Summary
Table 31. GlaxoSmithKline plc Beta-Lactam Drugs Product Offerings
Table 32. GlaxoSmithKline plc Beta-Lactam Drugs Revenue (US$, Mn), (2016-2021)
Table 33. Pfizer, Inc. Corporate Summary
Table 34. Pfizer, Inc. Beta-Lactam Drugs Product Offerings
Table 35. Pfizer, Inc. Beta-Lactam Drugs Revenue (US$, Mn), (2016-2021)
Table 36. AstraZeneca plc Corporate Summary
Table 37. AstraZeneca plc Beta-Lactam Drugs Product Offerings
Table 38. AstraZeneca plc Beta-Lactam Drugs Revenue (US$, Mn), (2016-2021)
Table 39. Merck & Co., Inc. Corporate Summary
Table 40. Merck & Co., Inc. Beta-Lactam Drugs Product Offerings
Table 41. Merck & Co., Inc. Beta-Lactam Drugs Revenue (US$, Mn), (2016-2021)
Table 42. Eli Lilly and Company Corporate Summary
Table 43. Eli Lilly and Company Beta-Lactam Drugs Product Offerings
Table 44. Eli Lilly and Company Beta-Lactam Drugs Revenue (US$, Mn), (2016-2021)
Table 45. Shionogi & Co., Ltd. Corporate Summary
Table 46. Shionogi & Co., Ltd. Beta-Lactam Drugs Product Offerings
Table 47. Shionogi & Co., Ltd. Beta-Lactam Drugs Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Beta-Lactam Drugs Segment by Type
Figure 2. Beta-Lactam Drugs Segment by Application
Figure 3. Global Beta-Lactam Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Beta-Lactam Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Beta-Lactam Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Beta-Lactam Drugs Revenue in 2020
Figure 8. By Type - Global Beta-Lactam Drugs Revenue Market Share, 2016-2027
Figure 9. By Application - Global Beta-Lactam Drugs Revenue Market Share, 2016-2027
Figure 10. By Region - Global Beta-Lactam Drugs Revenue Market Share, 2016-2027
Figure 11. By Country - North America Beta-Lactam Drugs Revenue Market Share, 2016-2027
Figure 12. US Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Beta-Lactam Drugs Revenue Market Share, 2016-2027
Figure 16. Germany Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 17. France Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Beta-Lactam Drugs Revenue Market Share, 2016-2027
Figure 24. China Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. India Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Beta-Lactam Drugs Revenue Market Share, 2016-2027
Figure 30. Brazil Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Beta-Lactam Drugs Revenue Market Share, 2016-2027
Figure 33. Turkey Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Beta-Lactam Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. GlaxoSmithKline plc Beta-Lactam Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Pfizer, Inc. Beta-Lactam Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. AstraZeneca plc Beta-Lactam Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Merck & Co., Inc. Beta-Lactam Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Eli Lilly and Company Beta-Lactam Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications